Ad is loading...
BBHLX
Price
$16.73
Change
-$0.20 (-1.18%)
Updated
Nov 15 closing price
RERAX
Price
$53.01
Change
-$0.52 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

BBHLX vs RERAX

Header iconBBHLX vs RERAX Comparison
Open Charts BBHLX vs RERAXBanner chart's image
BBH Partner Fund - International Eq I
Price$16.73
Change-$0.20 (-1.18%)
VolumeN/A
CapitalizationN/A
American Funds Europacific Growth R1
Price$53.01
Change-$0.52 (-0.97%)
VolumeN/A
CapitalizationN/A
BBHLX vs RERAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BBHLX vs. RERAX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BBHLX is a Sell and RERAX is a Buy.

FUNDAMENTALS
Fundamentals
RERAX has more cash in the bank: 129B vs. BBHLX (2.15B). RERAX pays higher dividends than BBHLX: RERAX (0.91) vs BBHLX (0.83). BBHLX was incepted earlier than RERAX: BBHLX (22 years) vs RERAX (22 years). BBHLX is a more actively managed with annual turnover of: 65.00 vs. RERAX (34.00). RERAX has a lower initial minimum investment than BBHLX: RERAX (250) vs BBHLX (10000). BBHLX annual gain was more profitable for investors over the last year : 16.60 vs. RERAX (7.63). BBHLX return over 5 years is better than : 4.91 vs. RERAX (3.85).
BBHLXRERAXBBHLX / RERAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years22 years-
Gain YTD8.0753.052265%
Front LoadN/AN/A-
Min. Initial Investment100002504,000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.15B129B2%
Annual Yield % from dividends0.830.9190%
Returns for 1 year16.607.63218%
Returns for 3 years-19.78-19.45102%
Returns for 5 years4.913.85127%
Returns for 10 years23.3715.89147%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APP291.096.60
+2.32%
Applovin Corp
BBDC9.950.06
+0.61%
Barings BDC
SIF3.60N/A
N/A
SIFCO Industries
CNS100.47-0.25
-0.25%
Cohen & Steers
FATE2.02-0.06
-2.88%
Fate Therapeutics